5% Human Normal Immunoglobulin Injection

Get a Price/Quote

MOQ : 100 Packs

5% Human Normal Immunoglobulin Injection Specification

Dosage Form
Injection

Salt Composition
Human Normal Immunoglobulin 5% w/v

Indication
Replacement therapy for primary and secondary immunodeficiency disorders; immune modulation

Feature
Sterile; preservative-free; purified; ready to use

Ingredients
Human Immunoglobulin G (IgG); stabilizers

Application
Intravenous administration

Ph Level
4.0 to 7.0

Physical Color/Texture
Clear to pale yellow solution

Fermentation Smell
Odorless

Storage Instructions
Store at 2C to 8C; do not freeze

Shelf Life
24 months

Pack Size
5 ml, 10 ml, 50 ml vials

Therapeutic Class
Immunological agents

Osmolality
240-350 mOsm/kg

Purity
>98% IgG

Container Type
Glass vial

Viral Inactivation
Solvent/detergent treatment and filtration

Type of Immunoglobulin
Polyclonal human IgG

IgA Content
<0.05 mg/ml

Strength
5% (50 mg/ml)

Precautions
Monitor for infusion-related reactions; ensure compatibility before administration

Manufacturing Method
Fractionation and purification of pooled human plasma

Contraindications
Hypersensitivity to human immunoglobulins, especially in selective IgA deficiency

Administration Route
Intravenous (IV) only

5% Human Normal Immunoglobulin Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

5% Human Normal Immunoglobulin Injection About

Experience the grandiose efficacy of our 5% Human Normal Immunoglobulin Injection, renowned as a best-seller across India. With competitive pricing and tailored pack sizes-5, 10, and 50 ml glass vials-you are invited to utilise our exclusive offer for bulk requirements. This preeminent immunological agent features >98% purity IgG, provided sterile, preservative-free, and ready-to-use. Its invincible safety profile ensures viral inactivation through solvent/detergent methods. Indicated for replacement therapy and immune modulation, it is an indispensable choice for healthcare professionals across diverse clinical settings.

Special Features and Wider Applications

Our 5% Human Normal Immunoglobulin Injection stands out with its high purity and sterility, ensuring optimal safety as a polyclonal human IgG preparation. Its other applications include controlling infections, supporting immunomodulatory therapy, and adjunct treatment in severe immune-complex diseases. Used by hospitals and clinics, this clear-to-pale yellow, odorless solution is the preferred choice for immunodeficient patients. Its exceptional compatibility and stringent purification are tailored for advanced immunological support and transfusion practices.

Export Markets and Sample Policy Highlights

This injection is actively dispatched to prominent export markets in Asia, Africa, and the Middle East, supported by a robust supply chain in India's main domestic market. Upon acceptance of purchase orders, we provide prompt quotations and reliable sample policies to facilitate informed purchasing decisions for distributors and healthcare institutions. Our streamlined export process ensures efficient delivery and compliance, positioning us as a trusted supplier for hospitals and wholesale traders internationally.

FAQ's of 5% Human Normal Immunoglobulin Injection:

Q: How should 5% Human Normal Immunoglobulin Injection be administered?

A: It is designed exclusively for intravenous (IV) administration and should be infused gradually, as per clinical recommendations and patient tolerance.

Q: What is the primary therapeutic benefit of this immunoglobulin injection?

A: The injection is primarily indicated for replacement therapy in primary and secondary immunodeficiency disorders, as well as for immune modulation in various medical conditions.

Q: When is this injection contraindicated?

A: It should not be used in individuals with known hypersensitivity to human immunoglobulins, especially those with selective IgA deficiency.

Q: Where should this product be stored?

A: Store the vials at 2C to 8C in a refrigerator. Avoid freezing to maintain efficacy and quality throughout the 24-month shelf life.

Q: What safety measures are involved in the manufacturing process?

A: Viral inactivation is achieved through solvent/detergent treatment and filtration. The fractionation and purification of pooled human plasma meet high safety and purity standards.

Q: How can customers request a sample or place a purchase order?

A: Interested buyers can request a quotation and sample through established channels. Upon purchase order confirmation, prompt dispatching and reliable supply are ensured.

Tell us about your requirement